Name:
Eutylone
Type:
Stimulant
AKA:
1-(1, 3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one, bk-EBDB
Eutylone image
Synthetic substance, no natural derivative
IUPAC Logo
Eutylone image
Eutylone, a synthetic stimulant, was first synthesized in the 2010s. It is known for its euphoric and stimulating effects. The compound's introduction reflects ongoing trends in designer stimulants. Eutylone's appearance in the recreational drug market has raised concerns about safety and regulatory control due to its potential for abuse and health risks.
Synthetic Substances Image
Eutylone is a synthetic stimulant with effects similar to MDMA. It acts as an upper, increasing euphoria and energy. Short-term use may enhance mood and alertness, but long-term use poses risks of cardiovascular issues and psychological problems. Overdose risks include severe agitation and cardiovascular effects. Safe use involves cautious dosing. Recent research explores its stimulant effects and potential health risks.
N/A
Eutylone, a stimulant and entactogen, affects monoamine systems, causing increased alertness and euphoria. Immediate effects include mood enhancement and cognitive stimulation, while long-term use can lead to dependence and psychological issues such as anxiety and cognitive decline. Research indicates significant mental health risks with chronic use.
N/A
Eutylone is a synthetic stimulant in the cathinone class, often associated with the recreational drug scene. Its emergence reflects the broader trend of novel psychoactive substances that are designed to mimic the effects of other stimulants or hallucinogens. Media coverage typically highlights its role in the rise of synthetic stimulants and the associated risks of adverse effects and addiction. Eutylone is used recreationally rather than medicinally, contributing to societal concerns about drug safety and the effectiveness of harm reduction strategies. Proponents might argue for personal freedom and exploration, while opponents emphasize the need for regulation and awareness of potential harms.
N/A